Skip Nav

Contact Us

Chondrosarcoma CS Foundation, Inc.

Thank you for your interest in our company. Complete the form below to send us an email, or simply give us a call. We're looking forward to working with you.

  • 301-352-3042

    OK!

    New Patient Registry Creates A Platform to Share Patient Journeys with Chondrosarcoma

    March 2nd, 2023The Chondrosarcoma Foundation in partnership with the National Organization for Rare Disorders (NORD®) has launched the Chondrosarcoma Patient Registry. Chondrosarcoma is a rare bone cancer that currently has no cure. Its prevalence and origin are...

    Read Article

    Rare Disease Day 2023: Empowering Community Advocacy And Innovation

    February 24th, 2023The time has come to make rare diseases a national public health imperative For decades, the rare disease community has been striving for greater recognition and scientific breakthroughs addressing the unmet medical needs millions of Americans face...

    Read Article

    Join the CS Foundation Patient / Caregiver / Family Advisory Board

    February 20th, 2023The Chondrosarcoma Foundation is developing a Patient / Caregiver / Family Advisory Board in the effort to create a voice for the chondrosarcoma community to address concerns and advocate for effective treatment and quality care. The advisory board...

    Read Article

    In Three Days: February 6: Chondrosarcoma Awareness Day

    February 3rd, 2023Join the Fight Wear A Yellow Ribbon on Monday, February 6. Post Your Picture to #CSWECARE Sign Our Petition for more Clinical Trials: www.csfshayna.org/support-cs-research/

    Read Article

    Remember the Contributions of David Bowles

    January 29th, 2023 We are just one week away from hosting Chondrosarcoma Awareness Day on February 6 (Shayna’s heavenly 32nd birthday). This is our international effort to educate the public about this rare bone cancer and to build a coalition to support more...

    Read Article

    Genomic profiling identifies genes and pathways dysregulated by HEY1-NCOA2 fusion and shines a light on mesenchymal chondrosarcoma tumorigenesis

    January 24th, 2023Abstract Mesenchymal chondrosarcoma is a rare, high-grade, primitive mesenchymal tumor. It accounts for around 2-10% of all chondrosarcomas and mainly affects adolescents and young adults. We previously described the HEY1-NCOA2 as a recurrent gene...

    Read Article

    Mike Snyder: A Pioneer with A Warrior Spirit

    January 22nd, 2023We are just two weeks away from hosting Chondrosarcoma Awareness Day on February 6 (Shayna’s heavenly 32nd birthday). This is our international effort to educate the public about this rare bone cancer and to build a coalition to support more...

    Read Article

    Julie Mathews and her determination to live life to the fullest and fight!

    January 10th, 2023We are just four weeks away from hosting Chondrosarcoma Awareness Day on February 6 (Shayna’s heavenly 32nd birthday). This is our international effort to educate the public about this rare bone cancer and to build a coalition to support more...

    Read Article